Expression patterns of biologic markers in small breast cancers and preneoplastic breast lesions

Breast

Volumn 9, Issue 5, 2000, Pages 281-285

  Krogerus, L A ^a   Leivonen, M ^b   Haasto A L ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b PEIJAS HOSPITAL   (Finland)

^c Maria Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CANCER ANTIBODY; FAS ANTIGEN; HERMES ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53;

ARTICLE; BREAST CANCER; BREAST DUCT; BREAST EPITHELIUM; BREAST HYPERPLASIA; BREAST LESION; BREAST PAPILLOMA; CANCER SIZE; CARCINOMA IN SITU; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MALIGNANT TRANSFORMATION; MORPHOLOGY; ONCOGENE NEU; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

EID: 0033730177     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2000.0141     Document Type: Article

References (21)

1. Risk factors for breast cancer in women with proliferative breast disease
2. Acase-control study of screendetected breast cancer in Miagi Prefecture, Japan
3. Risk factors for benign breast disease asccording to histopathological type: Comparisons for risk factors for breast cancer
4. The prognostic value of DNA ploidy and S-phase estimate in primary breast cancer: A prospective study
5. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorecence in situ hybridization and molecular analysis
6. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer
7. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia
8. Ductal carcinoma in situ of the breast: Correlation between histologic classifications and biologic markers
9. Prognostic classification of breast ductal carcinoma-in-situ
10. Histological prognosis and grading in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years
11. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
12. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinima in situ)
13. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma
14. Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-alpha expression in tumor cells correlates with resistance towards apoptosis
15. From hyperplasia to frank breast neoplasia. Carcinogenesis. Immunoprevention
16. Analysis of c-erb B-2 expression using a panel of 6 commercially available antibodies
17. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: Implication for mammary tumors
18. Expression of the 85-kd membrane protein in primary human breast cancer: Relationship to hormone receptor levels, DNA ploidy, and tumor grade
19. Impairment of Fas-antigen expression in adriamycin-resistant but not TNF-resistant MCF7 tumor cells
20. Molecular pathology of breast cancer and its application to clinical management
21. Expression and function of the cytokine receptor superfamily on breast cancer cells